Article
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.
Oncotarget - 4 Apr 2017
Zanusso Chiara, Bortolus Roberto, Dreussi Eva, Polesel Jerry, Montico Marcella, Cecchin Erika, Gagno Sara, Rizzolio Flavio, Arcicasa Mauro, Novara Giacomo, Toffoli Giuseppe
Abstract excerpt
The identification of biomarkers of biochemical recurrence (BCR) in prostate cancer (PCa) patients undergoing radiotherapy (RT) represents an unanswered clinical issue. The primary aim of this study was the definition of new genetic prognostic biomarkers in DNA repair genes (DRGs), considering both BCR and overall survival (OS) as clinical end-points. The secondary aim was to explore the potential clinical impact...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
